Fibrodysplasia Ossificans Progressiva (FOP) Terminated Phase 2 Trials for Palovarotene (DB05467)

Also known as: FOP / Fibrodysplasia Ossificans Progressiva / Myositis ossificans progressiva, unspecified site / Myositis ossificans progressiva / Progressive myositis ossificans / Progressive myositis ossificans (disorder)

IndicationStatusPhase
DBCOND0086420 (Fibrodysplasia Ossificans Progressiva (FOP))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02521792In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) SubjectsTreatment